BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35087921)

  • 1. Reconstruction of Human AML Using Functionally and Immunophenotypically Defined Human Haematopoietic Stem and Progenitor Cells as Targeted Populations.
    Zeisig BB; Fung TK; Troadec E; So CWE
    Bio Protoc; 2021 Dec; 11(24):e4262. PubMed ID: 35087921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional reconstruction of human AML reveals stem cell origin and vulnerability of treatment-resistant MLL-rearranged leukemia.
    Zeisig BB; Fung TK; Zarowiecki M; Tsai CT; Luo H; Stanojevic B; Lynn C; Leung AYH; Zuna J; Zaliova M; Bornhauser M; von Bonin M; Lenhard B; Huang S; Mufti GJ; So CWE
    Sci Transl Med; 2021 Feb; 13(582):. PubMed ID: 33627486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunophenotypically defined stem cell subsets in paediatric AML are highly heterogeneous and demonstrate differences in BCL-2 expression by cytogenetic subgroups.
    Petersen MA; Rosenberg CA; Brøndum RF; Aggerholm A; Kjeldsen E; Rahbek O; Ludvigsen M; Hasle H; Roug AS; Bill M
    Br J Haematol; 2022 May; 197(4):452-466. PubMed ID: 35298835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of haematopoietic stem cell regulatory programs in acute myeloid leukaemia.
    Basilico S; Göttgens B
    J Mol Med (Berl); 2017 Jul; 95(7):719-727. PubMed ID: 28429049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukaemia cell of origin identified by chromatin landscape of bulk tumour cells.
    George J; Uyar A; Young K; Kuffler L; Waldron-Francis K; Marquez E; Ucar D; Trowbridge JJ
    Nat Commun; 2016 Jul; 7():12166. PubMed ID: 27397025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells.
    Kawagoe H; Humphries RK; Blair A; Sutherland HJ; Hogge DE
    Leukemia; 1999 May; 13(5):687-98. PubMed ID: 10374871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease.
    Li Z; Chen P; Su R; Hu C; Li Y; Elkahloun AG; Zuo Z; Gurbuxani S; Arnovitz S; Weng H; Wang Y; Li S; Huang H; Neilly MB; Wang GG; Jiang X; Liu PP; Jin J; Chen J
    Cancer Res; 2016 Feb; 76(3):619-29. PubMed ID: 26747896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR4 chemokine receptors (CD184) and alpha4beta1 integrins mediate spontaneous migration of human CD34+ progenitors and acute myeloid leukaemia cells beneath marrow stromal cells (pseudoemperipolesis).
    Burger JA; Spoo A; Dwenger A; Burger M; Behringer D
    Br J Haematol; 2003 Aug; 122(4):579-89. PubMed ID: 12899713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C; Hassan HT
    Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia.
    Wong TN; Ramsingh G; Young AL; Miller CA; Touma W; Welch JS; Lamprecht TL; Shen D; Hundal J; Fulton RS; Heath S; Baty JD; Klco JM; Ding L; Mardis ER; Westervelt P; DiPersio JF; Walter MJ; Graubert TA; Ley TJ; Druley T; Link DC; Wilson RK
    Nature; 2015 Feb; 518(7540):552-555. PubMed ID: 25487151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
    Pituch-Noworolska A
    Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute myeloid leukemia cells secrete microRNA-4532-containing exosomes to mediate normal hematopoiesis in hematopoietic stem cells by activating the LDOC1-dependent STAT3 signaling pathway.
    Zhao C; Du F; Zhao Y; Wang S; Qi L
    Stem Cell Res Ther; 2019 Dec; 10(1):384. PubMed ID: 31842997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HCK maintains the self-renewal of leukaemia stem cells via CDK6 in AML.
    Li Z; Wang F; Tian X; Long J; Ling B; Zhang W; Xu J; Liang A
    J Exp Clin Cancer Res; 2021 Jun; 40(1):210. PubMed ID: 34167558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transformation of human CD34+ hematopoietic progenitor cells with DEK-NUP214 induces AML in an immunocompromised mouse model.
    Qin H; Malek S; Cowell JK; Ren M
    Oncogene; 2016 Oct; 35(43):5686-5691. PubMed ID: 27065320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The leukemia-associated Mll-Ell oncoprotein induces fibroblast growth factor 2 (Fgf2)-dependent cytokine hypersensitivity in myeloid progenitor cells.
    Shah CA; Bei L; Wang H; Platanias LC; Eklund EA
    J Biol Chem; 2013 Nov; 288(45):32490-32505. PubMed ID: 24089521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of acute myeloid leukaemia-associated mouse chromosome 2 deletions in X-ray exposed immature haematopoietic progenitors and stem cells.
    Olme CH; Brown N; Finnon R; Bouffler SD; Badie C
    Mutat Res; 2013 Aug; 756(1-2):119-26. PubMed ID: 23665297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR Gene Editing of Murine Blood Stem and Progenitor Cells Induces MLL-AF9 Chromosomal Translocation and MLL-AF9 Leukaemogenesis.
    Sarrou E; Richmond L; Carmody RJ; Gibson B; Keeshan K
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32549410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute myeloid leukemia-induced functional inhibition of healthy CD34+ hematopoietic stem and progenitor cells.
    Jäger P; Geyh S; Twarock S; Cadeddu RP; Rabes P; Koch A; Maus U; Hesper T; Zilkens C; Rautenberg C; Bormann F; Köhrer K; Petzsch P; Wieczorek D; Betz B; Surowy H; Hildebrandt B; Germing U; Kobbe G; Haas R; Schroeder T
    Stem Cells; 2021 Sep; 39(9):1270-1284. PubMed ID: 34013984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bortezomib suppresses self-renewal and leukemogenesis of leukemia stem cell by NF-ĸB-dependent inhibition of CDK6 in MLL-rearranged myeloid leukemia.
    Zhou B; Qin Y; Zhou J; Ruan J; Xiong F; Dong J; Huang X; Yu Z; Gao S
    J Cell Mol Med; 2021 Mar; 25(6):3124-3135. PubMed ID: 33599085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors.
    Sarris AH; Talpaz M; Deisseroth AB; Estrov Z
    Leukemia; 1996 May; 10(5):757-65. PubMed ID: 8656668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.